Melissa Wallace
Biographic Data
| ID | 6243156 |
|---|---|
| NAME | Melissa Wallace |
| GIVEN NAMES | Melissa |
| FAMILY NAME | Wallace |
| SIGNATURE | WALLACE M |
| AFFILIATIONS | Desmond Tutu HIV Foundation |
| ORCID | 0000-0001-7007-1910 |
| VERIFIED | Yes |
| TOTAL WORKS | 7 |
| TOTAL CITATIONS | 5 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 2 |
Oral PrEP use among pregnant or parenting young women in South Africa
Young women who are pregnant/parenting face elevated risk of early PrEP discontinuation. Differentiated, life-stage and youth-responsive interventions, such as counselling, partner involvement, and integration with maternal and child health, or sexual and reproductive health services, are critical to improving PrEP persistence among this priority population. This population should be prioritised in the rollout of long-acting PrEP formulations, wh…
FastPrEP
Adolescents and young people (AYP) are at increased risk of HIV acquisition and onward transmission in South Africa. The benefits of oral pre-exposure prophylaxis (PrEP) are well established, however, epidemic impact depends on access, effective use and scale-up. FastPrEP is an implementation science project that aims to scale up oral and novel PrEP modalities through differentiated service delivery to improve uptake and optimal use of PrEP in ke…
It’s already in your body and it’s preventing”
ClinicalTrials.gov ( NCT02404038 ). Registered March 31, 2015-Registered
Experiences with HPTN 067/Adapt Study-Provided Open-Label PrEP Among Women in Cape Town
Placebo-controlled trials of pre-exposure prophylaxis (PrEP) have reported challenges with study-product uptake and use, with the greatest challenges reported in studies with young women in sub-Saharan Africa. We conducted a qualitative sub-study to explore experiences with open-label PrEP among young women in Cape Town, South Africa participating in HTPN 067/Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (ADAPT). HPTN 067/ADA…
I’m Positive, But I’m Negative
HIV vaccine trials (HVTs) are ethically complex, and sound informed consent processes should facilitate optimal decision-making for participants. This study aimed to explore representations of critical HVT-related concepts to enhance the consent process. Four focus group discussions were conducted with participants from key constituencies at a South African HVT site. Thematic analysis was employed to identify representations of key HVT-related co…
Improving HIV testing amongst adolescents through an integrated Youth Centre rewards program
Preliminary results from Hlanganani (Coming Together)
I’m Positive, But I’m Negative
HIV vaccine trials (HVTs) are ethically complex, and sound informed consent processes should facilitate optimal decision-making for participants. This study aimed to explore representations of critical HVT-related concepts to enhance the consent process. Four focus group discussions were conducted with participants from key constituencies at a South African HVT site. Thematic analysis was employed to identify representations of key HVT-related co…
Preliminary results from Hlanganani (Coming Together)
Improving HIV testing amongst adolescents through an integrated Youth Centre rewards program
Improving HIV testing amongst adolescents through an integrated Youth Centre rewards program
Preliminary results from Hlanganani (Coming Together)
I’m Positive, But I’m Negative
HIV vaccine trials (HVTs) are ethically complex, and sound informed consent processes should facilitate optimal decision-making for participants. This study aimed to explore representations of critical HVT-related concepts to enhance the consent process. Four focus group discussions were conducted with participants from key constituencies at a South African HVT site. Thematic analysis was employed to identify representations of key HVT-related co…
Experiences with HPTN 067/Adapt Study-Provided Open-Label PrEP Among Women in Cape Town
Placebo-controlled trials of pre-exposure prophylaxis (PrEP) have reported challenges with study-product uptake and use, with the greatest challenges reported in studies with young women in sub-Saharan Africa. We conducted a qualitative sub-study to explore experiences with open-label PrEP among young women in Cape Town, South Africa participating in HTPN 067/Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (ADAPT). HPTN 067/ADA…
It’s already in your body and it’s preventing”
ClinicalTrials.gov ( NCT02404038 ). Registered March 31, 2015-Registered
FastPrEP
Adolescents and young people (AYP) are at increased risk of HIV acquisition and onward transmission in South Africa. The benefits of oral pre-exposure prophylaxis (PrEP) are well established, however, epidemic impact depends on access, effective use and scale-up. FastPrEP is an implementation science project that aims to scale up oral and novel PrEP modalities through differentiated service delivery to improve uptake and optimal use of PrEP in ke…
Oral PrEP use among pregnant or parenting young women in South Africa
Young women who are pregnant/parenting face elevated risk of early PrEP discontinuation. Differentiated, life-stage and youth-responsive interventions, such as counselling, partner involvement, and integration with maternal and child health, or sexual and reproductive health services, are critical to improving PrEP persistence among this priority population. This population should be prioritised in the rollout of long-acting PrEP formulations, wh…
HIV/AIDS Research and Interventions (6 works) · Medicine (5 works) · Adolescent Sexual and Reproductive Health (4 works) · Human immunodeficiency virus (HIV (4 works) · Public health (4 works) · Biostatistics (3 works) · Environmental health (3 works) · Family medicine (3 works) · Focus group (2 works) · HIV-related health complications and treatments (2 works)